Sarepta Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	801.28	1,103	428.43	966.78	2,116
Short-Term Investments	138.37	251.78	1,248	1,023	-
Cash & Short-Term Investments	939.65	1,355	1,676	1,989	2,116
Cash Growth	-30.64%	-19.18%	-15.74%	-5.98%	9.15%
Accounts Receivable	398.23	601.99	400.33	214.63	152.99
Inventory	914.74	749.96	322.86	203.97	186.21
Other Current Assets	285.31	366.72	179.9	149.89	149.03
Total Current Assets	2,538	3,073	2,579	2,558	2,604
Net Property, Plant & Equipment	470.62	488.65	357.11	244.99	236.69
Other Intangible Assets	-	-	-	-	14.24
Long-Term Investments	1.05	133.16	-	-	-
Other Long-Term Assets	340.1	267.9	328.14	325.51	292.95
Total Assets	3,350	3,963	3,265	3,128	3,148
Accounts Payable	280.84	214.44	164.92	95.88	76.74
Accrued Expenses	359.66	373.51	315	419	271.7
Current Portion of Long-Term Debt	-	-	105.48	-	-
Current Portion of Leases	-	-	-	15.49	-
Unearned Revenue	443.4	130.26	50.42	89.24	89.24
Other Current Liabilities	11.39	13.47	17.85	-	15.05
Total Current Liabilities	1,095	731.68	653.66	619.6	452.73
Long-Term Debt	828.97	1,137	1,133	1,544	1,097
Long-Term Leases	199.38	192.47	140.97	57.58	41.51
Other Long-Term Liabilities	85.44	374.15	478.1	521.94	628.84
Total Long-Term Liabilities	1,114	1,704	1,752	2,124	1,767
Total Liabilities	2,209	2,435	2,405	2,743	2,220
Common Stock	0.01	0.01	0	0.01	0.01
Treasury Stock	-25.26	-	-	-	-
Additional Paid-in Capital	6,043	5,739	5,305	4,297	4,135
Accumulated Other Comprehensive Income	0.27	-0.22	0.92	-1.66	-0.02
Retained Earnings	-4,877	-4,211	-4,446	-3,910	-3,207
Shareholders' Equity	1,141	1,528	859.34	384.95	928.01
Total Liabilities & Equity	3,350	3,963	3,265	3,128	3,148
Total Debt	1,028	1,330	1,379	1,617	1,138
Net Cash (Debt)	-88.7	25.2	297.29	372.02	977.48
Net Cash Growth	-	-91.53%	-20.09%	-61.94%	12.91%
Net Cash Per Share	-0.89	0.23	3.22	4.25	12.03
Book Value	1,141	1,528	859.34	384.95	928.01
Book Value Per Share	11.39	14.16	9.30	4.40	11.42
Tangible Book Value	1,141	1,528	859.34	384.95	913.77
Tangible Book Value Per Share	11.39	14.16	9.30	4.40	11.24

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q